The National Heart, Lung, and Blood Institute is offering grants to develop cutting-edge technologies for predictive, diagnostic, and therapeutic products in heart, lung, blood, and sleep-related disorders. Projects should address critical feasibility gaps and aim to accelerate early detection, treatment, and prevention of HLBS diseases. Applications must focus on transformative platforms rather than existing technologies. This funding opportunity is part of the NHLBI Catalyze Program to propel projects towards meeting entry criteria for further FOAs. Deadline for submission is August 11, 2021.
Opportunity ID: 320421
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-20-022 |
| Funding Opportunity Title: | Enabling Technologies and Transformative Platforms for HLBS Research (R33 – Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 09, 2019 |
| Last Updated Date: | Sep 09, 2019 |
| Original Closing Date for Applications: | Aug 11, 2021 |
| Current Closing Date for Applications: | Aug 11, 2021 |
| Archive Date: | Sep 16, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Private institutions of higher education Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases. This FOA solicits R33 applications where major feasibility gaps for the enabling technology or transformative platform have already been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage downstream demonstration, utilization and adoption. Well-suited applications must offer the potential to accelerate and/or transform the areas of early detection and screening, model development, clinical diagnosis, treatment, control, prevention or epidemiology, while addressing issues associated with HLBS-related diseases and disorders. Projects proposing application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not appropriate for this solicitation and will not be reviewed. This FOA is part of a suite of NHLBI Catalyze program to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Product Definition or Preclinical FOAs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00254703 | Oct 08, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260084 | Oct 08, 2019 | Aug 11, 2021 | View |
Package 1
Mandatory forms
320421 RR_SF424_2_0-2.0.pdf
320421 PHS398_CoverPageSupplement_4_0-4.0.pdf
320421 RR_OtherProjectInfo_1_4-1.4.pdf
320421 PerformanceSite_2_0-2.0.pdf
320421 RR_KeyPersonExpanded_2_0-2.0.pdf
320421 RR_Budget_1_4-1.4.pdf
320421 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
320421 RR_SubawardBudget30_1_4-1.4.pdf
320421 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
320421 RR_SF424_2_0-2.0.pdf
320421 PHS398_CoverPageSupplement_5_0-5.0.pdf
320421 RR_OtherProjectInfo_1_4-1.4.pdf
320421 PerformanceSite_2_0-2.0.pdf
320421 RR_KeyPersonExpanded_2_0-2.0.pdf
320421 RR_Budget_1_4-1.4.pdf
320421 PHS398_ResearchPlan_4_0-4.0.pdf
320421 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
320421 RR_SubawardBudget30_1_4-1.4.pdf
320421 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
